MedTrace Logo

Comparison of StentOptimizer With IntraVenous Ultrasound and 2D Quantitative Coronary Angiography

NCT00973921 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2014-04-11

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to determine the diagnostic efficiency and accuracy of using the StentOptimizer. The ability of StentOptimizer to influence post deployment treatment strategy will be assessed and compared to the IVUS system. In addition, the correlation of diameter measurements between the StentOptimizer, IVUS and 2D QCA will be assessed. The StentOptimizer software, IVUS and 2D QCA were all part of the clinical procedure outside the study. The analysis of post deployment treatment decisions and diameter measurements using those modalities retrospectively make this an observational study.

Conditions

Sponsors & Collaborators

  • Paieon Inc.

    lead INDUSTRY

Principal Investigators

  • Giora Weisz, MD · Columbia University

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00973921 on ClinicalTrials.gov